MedTrace Logo

Four-Week Oral Malodor and Clinical Safety for a Concentrated Cosmetic Mouthwash

NCT06479096 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 166

Last updated 2025-01-08

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety of the concentrated mouthwash prototypes, and to evaluate the efficacy of the concentrated mouthwash prototypes in the control of oral malodor compared to a comparator mouthwash and a negative control.

Conditions

  • Oral Malodor

Interventions

OTHER

Brush / Espresso Mild Prototype

Subjects will brush and rinse with their assigned mouthwash twice daily.

OTHER

Brush / Espresso Intense Prototype

Subjects will brush and rinse with their assigned mouthwash twice daily.

OTHER

Brush / Fresh Breath Oral Rinse

Subjects will brush and rinse with their assigned mouthwash twice daily.

OTHER

Brush / Hydroalcohol

Subjects will brush and rinse with their assigned mouthwash twice daily.

Sponsors & Collaborators

  • Johnson & Johnson Consumer and Personal Products Worldwide

    lead INDUSTRY

Principal Investigators

  • Jeffery Milleman, DDS · Salus Research Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-15
Primary Completion
2024-09-12
Completion
2024-09-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06479096 on ClinicalTrials.gov